DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target

Journal Article · · Journal of Medicinal Chemistry
 [1];  [1]; ORCiD logo [1];  [1];  [2];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [2];  [2];  [1];  [1];  [1];  [1] more »;  [1];  [3];  [3];  [3];  [3];  [3];  [4];  [4];  [5];  [5];  [5];  [6];  [6];  [6]; ORCiD logo [2]; ORCiD logo [1];  [3]; ORCiD logo [3]; ORCiD logo [1]; ORCiD logo [1] « less
  1. Univ. of Dundee (United Kingdom)
  2. Texas A & M Univ., College Station, TX (United States)
  3. GlaxoSmithKline, Madrid (Spain)
  4. Cornell Univ., Ithaca, NY (United States). Weill Medical College
  5. Colorado State Univ., Fort Collins, CO (United States)
  6. McGill Univ. Health Centre, Montreal, QC (Canada)

With increasing drug resistance in tuberculosis (TB) patient populations, there is an urgent need for new drugs. Ideally, new agents should work through novel targets so that they are unencumbered by preexisting clinical resistance to current treatments. Benzofuran 1 was identified as a potential lead for TB inhibiting a novel target, the thioesterase domain of Pks13. Although, having promising activity against Mycobacterium tuberculosis, its main liability was inhibition of the hERG cardiac ion channel. This article describes the optimization of the series toward a preclinical candidate. Despite improvements in the hERG liability in vitro, when new compounds were assessed in ex vivo cardiotoxicity models, they still induced cardiac irregularities. Further series development was stopped because of concerns around an insufficient safety window. However, the demonstration of in vivo activity for multiple series members further validates Pks13 as an attractive novel target for antitubercular drugs and supports development of alternative chemotypes.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER)
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
1844689
Journal Information:
Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Journal Issue: 1 Vol. 65; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (36)

Tuberculosis drug discovery in the post‐post‐genomic era journal January 2014
Fast Gradient HPLC Method to Determine Compounds Binding to Human Serum Albumin. Relationships with Octanol/Water and Immobilized Artificial Membrane Lipophilicity journal November 2003
An overview of new antitubercular drugs, drug candidates, and their targets journal May 2019
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development journal April 2003
A new stereospecific cross-coupling by the palladium-catalyzed reaction of 1-alkenylboranes with 1-alkenyl or 1-alkynyl halides journal January 1979
Tuberculosis journal March 2016
The WHO 2014 Global tuberculosis report—further to go journal January 2015
Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads journal September 2021
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13 journal July 2017
Mycolic Acids: Structures, Biosynthesis, and Beyond journal January 2014
The Polyketide Synthase Pks13 Catalyzes a Novel Mechanism of Lipid Transfer in Mycobacteria journal December 2014
Benzofuran derivatives and their anti-tubercular, anti-bacterial activities journal January 2019
A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm journal May 2020
High-Throughput Liquid Chromatography/Mass Spectrometry Method for the Determination of the Chromatographic Hydrophobicity Index journal July 2001
Easy-To-Synthesize Spirocyclic Compounds Possess Remarkable in Vivo Activity against Mycobacterium tuberculosis journal November 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis : Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization journal March 2018
A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP):  Theory and Application journal January 2007
New and Original p K a Prediction Method Using Grid Molecular Interaction Fields journal October 2007
Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy journal March 2004
Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening journal March 2004
Overcoming Undesirable hERG Potency of Chemokine Receptor Antagonists Using Baseline Lipophilicity Relationships journal February 2008
The challenge of new drug discovery for tuberculosis journal January 2011
Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis journal June 2013
New routes to tuberculosis treatment journal August 2017
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling journal November 2012
Genes required for mycobacterial growth defined by high density mutagenesis: Genes required for mycobacterial growth journal March 2003
Treatment of Tuberculosis journal November 2015
A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms journal December 2003
Comparison of Human Ether-à-go-go Related Gene Screening Assays Based on IonWorks Quattro and Thallium Flux journal December 2010
Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents journal November 2014
Fast Standardized Therapeutic-Efficacy Assay for Drug Discovery against Tuberculosis journal May 2010
Therapeutic Potential of Coumestan Pks13 Inhibitors for Tuberculosis journal April 2021
Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis journal January 2017
Phase 2 Early Afterdepolarization as a Trigger of Polymorphic Ventricular Tachycardia in Acquired Long-QT Syndrome: Direct Evidence From Intracellular Recordings in the Intact Left Ventricular Wall journal June 2001
Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis journal September 2013
New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics journal November 2013